CIK 0001367644 · Accelerated filer
Emergent BioSolutions Inc.
Sign in to watch- Ticker
- EBS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 141902018
- Phone
- 240-631-3200
- Business address
- 300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $145,792
- in 2 filings, $146K under 10b5-1 plans
Net −$145,792. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-12-08 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −18,674 | $9.01 | $168K | 144,460 |
| 2024-11-12 | DeGolyer Donald W Director | Sale | −25,000 | $10.91 | $273K | 111,100 |
| 2024-11-11 | White Marvin L Director | Sale | −14,287 | $11.97 | $171K | 54,092 |
| 2024-11-11 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −632 | $11.97 | $8K | 47,475 |
| 2024-10-15 | LINDAHL RICHARD S EVP, Chief Financial Officer | Grant or award | +15,000 | 171,009 | ||
| 2024-07-11 | Hartzel William SVP, Bioservices | Grant or award | +15,000 | 48,107 | ||
| 2024-07-11 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Grant or award | +15,000 | 186,382 | ||
| 2024-07-08 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −85 | $8.13 | $691 | 24,333 |
| 2024-06-08 | Fox Jennifer Lynne EVP, Ext Aff, GC, Corp Sec | Shares withheld for taxes | −2,376 | $6.19 | $15K | 171,382 |
| 2024-06-08 | Williams Paul Anthony SVP, Products Business | Shares withheld for taxes | −464 | $6.19 | $3K | 24,418 |
| 2024-06-08 | Glessner Coleen EVP, Quality & Ethics, and CPL | Shares withheld for taxes | −1,249 | $6.19 | $8K | 163,134 |
| 2024-06-08 | LINDAHL RICHARD S EVP, Chief Financial Officer | Shares withheld for taxes | −2,733 | $6.19 | $17K | 156,009 |
| 2024-06-08 | Hartzel William SVP, Bioservices | Shares withheld for taxes | −1,167 | $6.19 | $7K | 33,107 |
| 2024-06-04 | Zoon Kathryn C Director | Sale | −10,000 | $6.11 | $61K | 54,482 |
| 2024-05-29 | Zoon Kathryn C Director | Sale | −1,830 | $4.61 | $8K | 64,482 |
| 2024-05-23 | Katkin Keith Director | Grant or award | +17,430 | 59,872 | ||
| 2024-05-23 | Katkin Keith Director | Grant or award · Stock Option (Right to Buy) | +25,748 | 25,748 | ||
| 2024-05-23 | Fowler Neal Franklin Director | Grant or award | +17,430 | 136,100 | ||
| 2024-05-23 | Fowler Neal Franklin Director | Grant or award · Stock Option (Right to Buy) | +25,748 | 25,748 | ||
| 2024-05-23 | DeGolyer Donald W Director | Grant or award | +17,430 | 136,100 |
Page 8 of 17 · 330 trades